BioCryst Pharmaceuticals | BCRX - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Chugai Pharma JPY 392.19B 64.49B 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
DBV Technologies USD 54.3M 2.5M 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novavax USD 330.57M 11.89M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06